This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Agency for Science, Technology and Research. Active years: 2014-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2016
Title: Innovations of Dominik Janczewski
Introduction
Dominik Janczewski is a notable inventor based in Singapore, SG. He has made significant contributions to the field of nanotechnology, particularly in the development of cell-targeting nanoparticles and amphiphilic polymers. With a total of 2 patents, his work is paving the way for advancements in targeted drug delivery systems.
Latest Patents
Janczewski's latest patents include "Cell-targeting nanoparticles and uses thereof" and "Amphiphilic polymers and nanocrystals coated therewith." The first patent refers to a cell-targeting nanoparticle that is directly conjugated to at least one cysteine-containing peptide. This peptide is selected from a group that includes glutathione and peptides with nuclear localization signals. The methods of using these nanoparticles have potential applications in targeted therapies. The second patent describes an amphiphilic polymer comprising various repeat units, which can be utilized in creating nanocrystals for diverse applications.
Career Highlights
Dominik Janczewski is affiliated with the Agency for Science, Technology and Research, where he continues to innovate and contribute to scientific advancements. His research focuses on the intersection of chemistry and biology, aiming to enhance the efficacy of therapeutic agents.
Collaborations
Janczewski has collaborated with esteemed colleagues such as Ming-Yong Han and Kishore K Bhakoo. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in their respective fields.
Conclusion
Dominik Janczewski's work exemplifies the spirit of innovation in the realm of nanotechnology. His patents reflect a commitment to advancing medical science through targeted delivery systems. The impact of his inventions is likely to resonate in the scientific community for years to come.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
